However, in the group with low FXYD2 mRNA expression, chemotherapy status was not an independent factor affecting the survival of patients with glioma (univariate Cox analysis P = 0.132; multivariate Cox analysis P = 0.174; Table 3). The gene discussed is FXYD2; the disease is central nervous system cancer.